Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

Similar documents
Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

Trial Management: Trial Master Files and Investigator Site Files

VCU Clinical Research Quality Assurance Assessment

Good Clinical Practice: A Ground Level View

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

WIRBinar. How to Survive an FDA Inspection. Upcoming Trainings: Contact Us: (360)

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Study Initiation Meeting

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

The GCP Perspective on Study Monitoring

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees

BIMO SITE AUDIT CHECKLIST

1. INTRODUCTION 2. SCOPE 3. PROCESS

Checklist prior to recruiting first patient

Clinical Study Risk Assessment

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

Standard Operating Procedure (SOP) Research and Development Office

SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES

QUALITY ASSURANCE PROGRAM

QUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Document Title: Study Data SOP (CRFs and Source Data)

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System

Essential Documents It s Not Just a Binder!

Self-Monitoring Tool

FDA Medical Device Regulations vs. ISO 14155

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

Standard Operating Procedure (SOP) Research and Development Office

managing or activities.

STH Researcher. Recording of research information in patient case notes

National Drug Abuse Treatment Clinical Trials Network

GCP INSPECTION CHECKLIST

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

Investigator Site File Standard Operating Procedure (SOP)

12.0 Investigator Responsibilities

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

Roles & Responsibilities of Investigator & IRB

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

Standard Operating Procedures

FDA Inspection Readiness

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

IN ACCORDANCE WITH THIS INTERNATIONAL DEVICE STANDARD

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Vertex Investigator-Initiated Studies Program Overview

RITAZAREM CRF Completion Guidelines

SAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California. STANDARD OPERATING PROCEDURES Institutional Review Board

Course program. Good Clinical Practice (GCP) course for surgeons

Clinical Trial Readiness Checklist October 2014

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Monitoring Clinical Trials

EMA & FDA Inspections: Site perspective. Shandukani Research Centre

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

Standard Operating Procedures (SOP) Research and Development Office

Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Clinical Trial Quality Assurance Common Findings

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)

STANDARD OPERATING PROCEDURE SOP 325

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

Overview ICH GCP E6(R2) Integrated Addendum

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

Building Quality into Clinical Trials. Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

Effective Date: 11/09 Policy Chronicle:

Good Documentation Practices. Human Subject Research. for

STANDARD OPERATING PROCEDURE

PLATELET-ORIENTED INHIBITION ISCHEMIC STROKE (POINT) MONITORING PLAN IN NEW TIA AND MINOR. Version 2.0 Updated 11 May 2017

LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)

Request to Use an External IRB as an IRB of Record

Standard Operating Procedure Research Governance

Setting up a Clinical Trial

Research Staff Training

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Registration/Contract of Supervisor for Counseling Licensure. Applicant Information (Please type or print clearly)

A Screen patients G Review/Accountability/Sign off Form 2:Dosing Log M IMP Supply/Management. SAE clinical review/causality Assessment and Sign off

OFFICE FOR RESEACH PROCEDURE. Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records

Keele Clinical Trials Unit

Prescriptive Authority & Protocol Agreement

IRBNet Instructions for Investigators

Auditing of Clinical Trials

ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM

Section 9. Study Product Considerations for Non- Pharmacy Staff

Unofficial copy not valid

Local VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB

Joint R&D Support Office SOP S-2011 UHL

Transcription:

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

INFORMATION AND GUIDANCE SHEET FOR THE COMPLETION OF THE SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG The purpose of the Site Signature and Delegation of Responsibilities Log To fulfill the requirements stated in ICH GCP E6 Guideline Section 4.1.5 the Investigator should maintain a list of appropriately qualified and trained persons to whom the Investigator has delegated significant study related duties and to document study-specific roles and responsibilities assigned to all staff on the study team by the Investigator. To fulfil the requirement in Section 8 of ICH GCP 8.3.24 signature sheet to document signatures and initials of all persons authorized to make entries and/or corrections on CRFs. Important notes All personnel who have been delegated significant study related duties or tasks, which the Principal Investigator would otherwise do, must be listed on the log. The intention of the log is not to capture every task that an individual may perform, but to list the study personnel and the key study duties/tasks that they have been delegated. This would be any duty/ task that could impact significantly on subject safety, protocol compliance, quality and the integrity of the study data. A selection of study tasks have been listed on the log, however protocols may have additional tasks not listed. It is important to work with the sponsor to define additional study specific tasks and add them to the Other section on the log.»» Information entered in all sections of the log should be legible and correct. The Principal Investigator and site staff who have been delegated duties/tasks should use the same signature and initials, as provided on the site signature and delegation of responsibility log, when signing and initialing patient records and any study related documents. The signature and initial columns need to be handwritten to allow validation of signatures/initials used for study related documentation e.g. consent form, source documents, CRF entry, drug logs, etc. 2

The log must be updated in a timely manner as personnel are added or removed and/or study roles and responsibilities change. Changes must be approved by Principal Investigator before they are implemented (as indicated by his/her initials). All staff delegated to significant study related duties must show evidence of education and training appropriate to the role to confirm that they are qualified to perform the delegated task. The evaluation of whether study staff is performing functions within the scope of their professional licensure depends not only on the scope of their licensure, but also on local regulations. Thus, the professional licensing authority in the State(s), Province(s) or Country (ies) in which the study is taking place makes the final determination. Each investigational site should be aware of their local regulations as to what the scope of practice is. Change of Principal Investigator. If during the course of the study there is a change in the Principal Investigator the current Principal Investigator should complete the end date,(end column in the table), as the final date on the study. The new Principal Investigator should complete a new log. The new Principal Investigator may specify in the comments section that he/she has reviewed all previously delegated tasks and is in agreement with the delegations or to clarify any changes in delegated tasks for site staff members. Role or Key Study Tasks Change. The Principal Investigator is required to initial and date changes to confirm and acknowledge any additional or deleted tasks. If the role of a staff member changes during the course of the study, an end date should be entered at the time the role is no longer being completed by the individual. If there are any changes to study tasks for an individual, the current delegation line should be updated with an end date. A new line is then started with the updated delegated study tasks. It is important to ensure that it is clear on the log what tasks the individual has been delegated to perform. If extra space is required for any fields, use the next line below. If extra rows are needed in the completion of this log then, duplicate the third page of the Site Signature and Delegation of Responsibilities Log and number pages accordingly (3a,3b,etc). If satellite sites are involved in the study please discuss with your Sponsor how best to complete this log.»» The original log should be retained at the site and kept up to date. Determine with the Sponsor what their requirements are. 3

The completion of the log Study Sponsor: Enter name of the sponsor company Principal Investigator: Enter the name of the Principal Investigator Protocol/Study Number: Country: Enter the Protocol/study number designated on the protocol Country in which the study site resides Study site Number: Enter the study site number. This number is specific for the site Name of Principal Investigator Principal Investigator s Signature* Principal Investigators Initials Start End Enter the legal name of the Principal Investigator. The Principal Investigator signs here. The Principal Investigator enters his/her initials. This date records the commencement of any study related activities. This date records the cessation of all Principal Investigator study related activities due to the study ending or a change in Principal Investigator. In the event that the Principal Investigator changes, the end date will be recorded and a new log will be completed by the new Principal Investigator prior to them commencing any study activities. Both the original and the new log will be held by the site. 4

Name Signature (my signature below indicates that I accept the study task.) Initials Study Role Study Task (Select from key) Name of person who will have duties/tasks delegated to them. Signature of the person who has accepted delegated duties/ tasks. Initials of the person who has accepted delegated duties/ tasks. Identity the role of the person who as accepted delegated duties/tasks. A selection of study tasks is listed on the log and in this guidance. Start of task PI Initials End of task Date when the duty or task ended or when the study was completed. PI Initials Date of when the duty or task was delegated. Initials by the Principal Investigator to confirm this delegation. Initials by the Principal Investigator to confirm that the duty or task has ended. Name Print or write legibly the full legal names of the site staff members who will be assigned key study tasks related to the clinical study/study. Always record only one name per line. Signature Each individual assigned a task must sign in the column next to their name. This signature will be used to compare entries made later on study related documentation by the individual. Please note, in some regions there may be more than one signature in addition to the English signature; in this case, both signatures should be captured on the log. Initials Each individual enters her/his initials as they will appear on any study related documentation. Initials are generally defined as the first letter of the person s first (given) name and last (family) name. If another way of recording initials is used as a common practice then this can be accepted. Study Role Enter the site staff s study-specific role next to their name on each line. Examples of study roles may include but are not limited to: Sub-Investigator Study Coordinator Pharmacist Study nurse 5

Study Tasks Use the study task key to assign the tasks delegated. Record the numbers corresponding to the tasks. Numbers recorded can be consecutive numbers, or range, e.g. 1,3,5,6, or 1-4; 8-11. Ensure that tasks are aligned with the roles, expertise and training of the individuals. If there are additional study-specific tasks that are not included on the log, use the Other designation and specify the task. Consult the Sponsor on what these tasks may be. 1. Coordinates IRB/ EC communications 2. Screens/recruits study subjects 3. Obtains Informed Consent 4. Confirms eligibility (Inclusion/ Exclusion) 5. Obtains medical history 6. Performs physical examination 7. Conducts study visit procedures 8. Makes study related medical decisions 9. Evaluates study related test results 10. Performs study-related assessments 11. Assesses AEs/SAEs 12. Reports SAEs 13. Stores study drug and monitors temperature 14. Collects samples 15. Processes biologic sample and ships sample 16. Uses IWRS/IVRS 17. Makes entries/ corrects e/crfs 18. Signs-off e/crfs 19. Resolves data queries 20. Maintains essential documents 21. Prepares/dispenses study drug/device 22. Manages study drug/device accountability 23. Activities related to Regulatory submissions 24. Activities related to code break 25. Other (*) 26. Other (*) 27. Other (*) 28. Other (*) Start of task (format: dd/mmm/yy) Start indicates the start date when the individual has been delegated study tasks (not necessarily when the Principal Investigator has added the staff to the study team). Note: All study training appropriate to the role should be completed prior to the delegation of the task. No study related tasks can be performed prior to training. End of task (format: dd/mmm/yy) End indicates the date when the individual is no longer participating on the study. For each site staff individual, this may be a different date depending on when their involvement in the study has concluded. The End Date should be left blank unless the individual s involvement concluded prior to the end of the study, at which point, an end date should be entered. If no entry is made in this column, it is assumed that the tasks were conducted until the completion of the study (the date of the close-out visit). After End Date, the particular person will not undertake any delegated tasks and all passwords/accesses for study related systems must be terminated. 6

Principal Investigator Initials The Principal Investigator records his/her initials at the time of adding to or making changes to the log to acknowledge that the delegations to the staff are correct. By initialing the start, the Principal Investigator confirms the particular staff member is authorized, trained appropriate to the role and qualified to perform the tasks assigned to him/her. This information about the staff member is not complete without the Principal Investigator s initials. Once the particular staff member is no longer delegated to the task the Principal Investigator must initial to verify this fact. Comments The Principal Investigator may use this space to clarify any changes that were not possible to document on the log. An example can be acknowledgement by the new Principal Investigator that he/she has reviewed and is in agreement with tasks delegated by the previous Principal Investigator. At the conclusion of the study, the log should be signed and dated in the designated area by the Principal Investigator after reviewing all entries for accuracy. The completed log should remain at the site in accordance with Sponsor requirements. 7